Related Experiment Video
Updated: Feb 22, 2026

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
Glycemic control in patients undergoing coronary artery bypass graft surgery: Clinical features, predictors, and
Judson B Williams1, Eric D Peterson2, Álvaro S Albrecht3
1Duke Clinical Research Institute, Durham, NC, United States; Department of Surgery, Duke University School of Medicine, Durham, NC, United States; WakeMed Clinical Research Institute, WakeMed Health and Hospitals, Raleigh, NC, United States.
Insights
Good glycemic control after high-risk cardiac surgery is linked to better outcomes but is achieved in only 15% of patients. Hospital performance in managing blood sugar varies significantly, impacting patient prognosis.
Area of Science:
- Cardiology
- Endocrinology
- Critical Care Medicine
Background:
- Hyperglycemia in critically ill patients is associated with poorer prognosis.
- The impact of glycemic control on outcomes after Coronary Artery Bypass Graft (CABG) surgery is not well-established.
Purpose of the Study:
- To evaluate the achievement of glycemic control in the perioperative period following high-risk CABG surgery.
- To determine the association between glycemic control and clinical outcomes, including mortality and major complications.
Main Methods:
- A study involving 2032 patients undergoing high-risk CABG across 55 US hospitals.
- Good glycemic control defined as blood sugar (BS) between 70-180 mg/dL within 24 hours post-surgery.
- Generalized estimating equations logistic regression models were used for analysis, adjusting for baseline characteristics.
Main Results:
- Only 15% of patients achieved good glycemic control (70-180 mg/dL).
- Patients with good glycemic control had significantly lower rates of mortality and major complications (OR=0.66; p=0.02).
- Hypoglycemic events occurred in 12% of patients, with wide hospital variation (2%-58%), unrelated to overall good glucose control rates.
Conclusions:
- Achieving perioperative glycemic control in high-risk CABG patients is associated with reduced mortality and morbidity.
- Good glycemic control was achieved in only 15% of patients, indicating a significant gap in care.
- There was considerable variation among hospitals in their ability to achieve target glycemic control.
Purpose:
Critically ill patients with hyperglycemia have worse prognosis. The degree to which glycemic control is achieved following CABG surgery and the association with clinical outcomes is not well understood.
Materials And Methods:
We studied patients undergoing higher risk CABG surgery at 55 US hospitals. Good glycemic control was defined as 70-180mg/dL in the first 24h postoperatively. Generalized estimating equations logistic regression models were used to assess the relationship between glycemic control and clinical outcomes after adjusting for baseline characteristics.
Results:
Among 2032 patients only 297 (15%) had good glycemic control in the perioperative period, with 2% having at least one BS below 70, 63% having at least one BS above 180, and 9% having both. Patients with good glycemic control had lower rates of the risk-adjusted composite outcome of mortality and major complications (OR=0.66; 95% CI 0.46-0.93, p=0.02). Hypoglycemic events occurred in 250 (12%) patients, ranging among hospitals from 2% to 58%, p<0.001 and was not associated with hospitals' overall rate of good glucose control.
Conclusions:
Achieving glycemic control following high risk CABG was associated with lower operative mortality and morbidity, yet achieved in only 15% of patients. Hospitals varied considerably in their ability to achieve good glycemic control.
Related Concept Videos
Peripheral Artery Disease V: Postoperative Nursing Management
Coronary Artery Disease V: Interprofessional Care
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Coronary Artery Disease III: Clinical Manifestations
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Diabetes Mellitus: Type 2 and Gestational

